Contact
Please use this form to send email to PR contact of this press release:
INVESTOR ALERT: Edelson Lechtzin LLP is Investigating Securities Fraud Claims on Behalf of Eiger BioPharmaceuticals, Inc. (NASDAQ: EIGR) Shareholders
TO: